<DOC>
	<DOC>NCT00297687</DOC>
	<brief_summary>To determine the safety &amp; immunogenicity of a potential vaccine against meningococcal B disease</brief_summary>
	<brief_title>Study Evaluating the Safety, Immunogenicity and Tolerability of Meningococcal Group B Vaccine in Healthy Adults</brief_title>
	<detailed_description />
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Meningitis, Meningococcal</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy 1825 year olds Prior history of vaccination with any meningococcal vaccine Prior history of any invasive meningococcal disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Vaccines</keyword>
	<keyword>Healthy Adults</keyword>
	<keyword>Health</keyword>
	<keyword>Adult</keyword>
	<keyword>Meningococcal Vaccines</keyword>
</DOC>